Details for Patent: 4,753,935
✉ Email this page to a colleague
Summary for Patent: 4,753,935
| Title: | Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions |
| Abstract: | The compounds and pharmaceutical compositions of Formula A, wherein Z is hydrogen or --C(O)R, where R is lower alkyl or aryl, and the pharmaceutically acceptable salts thereof, are useful as immunosuppressive agents, anti-inflammatory agents, anti-tumor agents, anti-viral agents, and anti-psoriatic agents. ##STR1## |
| Inventor(s): | Peter H. Nelson, Chee-Liang L. Gu, Anthony C. Allison, Elsie M. Eugui, William A. Lee |
| Assignee: | Hoffmann La Roche Inc , Roche Holdings Inc |
| Application Number: | US07/008,717 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 4,753,935
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 4,753,935
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 0281713 | ⤷ Start Trial | SPC/GB96/026 | United Kingdom | ⤷ Start Trial |
| European Patent Office | 0281713 | ⤷ Start Trial | 96C0031 | Belgium | ⤷ Start Trial |
| European Patent Office | 0281713 | ⤷ Start Trial | C960019 | Netherlands | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
